Diana C Yanez, Jasmine Rowell, Maximillian Woodall, Stuart Adams, Lauran O'Neill, Konstantinos Mengrelis, Ching-In Lau, Susan Ross, Sarah Benkenstein, Kate Plant, Claire M Smith, Benny Chain, Mark J Peters, Tessa Crompton
{"title":"PIMS-TS/MIS-C患者独特的TCR曲目:可能累及胸腺。","authors":"Diana C Yanez, Jasmine Rowell, Maximillian Woodall, Stuart Adams, Lauran O'Neill, Konstantinos Mengrelis, Ching-In Lau, Susan Ross, Sarah Benkenstein, Kate Plant, Claire M Smith, Benny Chain, Mark J Peters, Tessa Crompton","doi":"10.1093/cei/uxaf027","DOIUrl":null,"url":null,"abstract":"<p><p>During the COVID-19 pandemic a rare new paediatric inflammatory condition (paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS)/MIS-C) was identified which correlated with previous or recent SARS-CoV-2 infection. PIMS-TS led to severe multi-organ inflammation, suggestive of disruption of central tolerance and thymus function. Here we investigated the possible role of the thymus in paediatric PIMS-TS. We confirmed that human thymus explants can be infected with SARS-CoV-2 in vitro. Comparison of T-cell populations in blood from PIMS-TS patients and age-matched healthy control children showed that although the overall proportions of CD4 and CD8 T-cell populations were decreased in PIMS-TS patients, the proportion of naïve cells in the CD4 population was higher in the PIMS-TS group. In PIMS-TS patients, the number of TREC in PBMC correlated strongly with the proportion of naive CD4 and CD8 T-cells, whereas this correlation was not present in healthy children. Sequencing rearranged TCRα and TCRβ transcripts from FACS-sorted CD4+CD8-CD3+ and CD4-CD8+CD3+ from blood from PIMS-TS, healthy children, and additionally paediatric severe COVID-19 patients, showed that while all three groups showed similar diversity and distribution, the repertoire of the PIMS-TS and COVID-19 groups had distinctive patterns of TCR gene segment usage and VJ combinatorial usage compared to healthy controls (TRBV11-2xTRBJ2-7, TRBV11-2xTRBJ1-1, TRBV11-2xTRBJ2-5, TRBV11-2xTRBJ2-1; TRBV29-1xTRBJ2-7, TRBV29-1xTRBJ1-1 enriched in PIMS-TS; TRBV7-9xTRBJ1-2, TRAV9-2xTRAJ30 and TRAV26-1xTRAJ39 enriched in COVID-19). The non-productive TCR rearrangements in the PIMS-TS group were also enriched for TRBV11-2, and showed bias towards distal (5'TRAV to 3'TRAJ) TCR gene segment usage, suggesting involvement of the thymus in PIMS-TS.</p>","PeriodicalId":10268,"journal":{"name":"Clinical and experimental immunology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Distinctive TCR repertoire in PIMS-TS/MIS-C patients: possible thymus involvement.\",\"authors\":\"Diana C Yanez, Jasmine Rowell, Maximillian Woodall, Stuart Adams, Lauran O'Neill, Konstantinos Mengrelis, Ching-In Lau, Susan Ross, Sarah Benkenstein, Kate Plant, Claire M Smith, Benny Chain, Mark J Peters, Tessa Crompton\",\"doi\":\"10.1093/cei/uxaf027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>During the COVID-19 pandemic a rare new paediatric inflammatory condition (paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS)/MIS-C) was identified which correlated with previous or recent SARS-CoV-2 infection. PIMS-TS led to severe multi-organ inflammation, suggestive of disruption of central tolerance and thymus function. Here we investigated the possible role of the thymus in paediatric PIMS-TS. We confirmed that human thymus explants can be infected with SARS-CoV-2 in vitro. Comparison of T-cell populations in blood from PIMS-TS patients and age-matched healthy control children showed that although the overall proportions of CD4 and CD8 T-cell populations were decreased in PIMS-TS patients, the proportion of naïve cells in the CD4 population was higher in the PIMS-TS group. In PIMS-TS patients, the number of TREC in PBMC correlated strongly with the proportion of naive CD4 and CD8 T-cells, whereas this correlation was not present in healthy children. Sequencing rearranged TCRα and TCRβ transcripts from FACS-sorted CD4+CD8-CD3+ and CD4-CD8+CD3+ from blood from PIMS-TS, healthy children, and additionally paediatric severe COVID-19 patients, showed that while all three groups showed similar diversity and distribution, the repertoire of the PIMS-TS and COVID-19 groups had distinctive patterns of TCR gene segment usage and VJ combinatorial usage compared to healthy controls (TRBV11-2xTRBJ2-7, TRBV11-2xTRBJ1-1, TRBV11-2xTRBJ2-5, TRBV11-2xTRBJ2-1; TRBV29-1xTRBJ2-7, TRBV29-1xTRBJ1-1 enriched in PIMS-TS; TRBV7-9xTRBJ1-2, TRAV9-2xTRAJ30 and TRAV26-1xTRAJ39 enriched in COVID-19). The non-productive TCR rearrangements in the PIMS-TS group were also enriched for TRBV11-2, and showed bias towards distal (5'TRAV to 3'TRAJ) TCR gene segment usage, suggesting involvement of the thymus in PIMS-TS.</p>\",\"PeriodicalId\":10268,\"journal\":{\"name\":\"Clinical and experimental immunology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-05-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and experimental immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/cei/uxaf027\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cei/uxaf027","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Distinctive TCR repertoire in PIMS-TS/MIS-C patients: possible thymus involvement.
During the COVID-19 pandemic a rare new paediatric inflammatory condition (paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS)/MIS-C) was identified which correlated with previous or recent SARS-CoV-2 infection. PIMS-TS led to severe multi-organ inflammation, suggestive of disruption of central tolerance and thymus function. Here we investigated the possible role of the thymus in paediatric PIMS-TS. We confirmed that human thymus explants can be infected with SARS-CoV-2 in vitro. Comparison of T-cell populations in blood from PIMS-TS patients and age-matched healthy control children showed that although the overall proportions of CD4 and CD8 T-cell populations were decreased in PIMS-TS patients, the proportion of naïve cells in the CD4 population was higher in the PIMS-TS group. In PIMS-TS patients, the number of TREC in PBMC correlated strongly with the proportion of naive CD4 and CD8 T-cells, whereas this correlation was not present in healthy children. Sequencing rearranged TCRα and TCRβ transcripts from FACS-sorted CD4+CD8-CD3+ and CD4-CD8+CD3+ from blood from PIMS-TS, healthy children, and additionally paediatric severe COVID-19 patients, showed that while all three groups showed similar diversity and distribution, the repertoire of the PIMS-TS and COVID-19 groups had distinctive patterns of TCR gene segment usage and VJ combinatorial usage compared to healthy controls (TRBV11-2xTRBJ2-7, TRBV11-2xTRBJ1-1, TRBV11-2xTRBJ2-5, TRBV11-2xTRBJ2-1; TRBV29-1xTRBJ2-7, TRBV29-1xTRBJ1-1 enriched in PIMS-TS; TRBV7-9xTRBJ1-2, TRAV9-2xTRAJ30 and TRAV26-1xTRAJ39 enriched in COVID-19). The non-productive TCR rearrangements in the PIMS-TS group were also enriched for TRBV11-2, and showed bias towards distal (5'TRAV to 3'TRAJ) TCR gene segment usage, suggesting involvement of the thymus in PIMS-TS.
期刊介绍:
Clinical & Experimental Immunology (established in 1966) is an authoritative international journal publishing high-quality research studies in translational and clinical immunology that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice.
The journal is focused on translational and clinical immunology and is among the foremost journals in this field, attracting high-quality papers from across the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through scientific studies to the treatment, prevention or diagnosis of human disease. Clinical immunology has evolved as a field to encompass the application of state-of-the-art technologies such as next-generation sequencing, metagenomics and high-dimensional phenotyping to understand mechanisms that govern the outcomes of clinical trials.